-+ 0.00%
-+ 0.00%
-+ 0.00%
Tewa Pharmaceuticals revenue for the third quarter was US$4.4 billion, and the market estimate is US$4.24 billion.
Share
Listen to the news
Tewa Pharmaceuticals revenue for the third quarter was US$4.4 billion, and the market estimate is US$4.24 billion.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending